biotech
Stronger Avian Flu Vaccine From GlaxoSmithKline
Filed in archive Corporate and Industrial News , Drugs, Vaccines and Therapeutics by ruth on July 27, 2006
Stronger Avian Flu Vaccine From GlaxoSmithKline
GlaxoSmithKline reports the results of clinical trials of its vaccine against bird flu, which has demonstrated that more than 80% of the subjects were protected by two shots, each containing only 3.8 micrograms of an antigen. This is a far better performance than the current vaccine on stockpile -- which is manufactured by Sanofi-Pasteur-- which demonstrated 50% protection after two doses of 90 micrograms each.

According to a New York Times article, GlaxoSmithKline will seek regulatory approval from the FDA this year, and if approved, the avian flu vaccine will sell for the same price as a standard flu shot, i.e., $8 to $12 a shot.

Read the full story here.

Permalink: Stronger Avian Flu Vaccine From GlaxoSmithKline
Tags: vaccine  flu  biotech  avian  glaxosmithkline  avian+vaccine  stronger+avian  food+agriculture 
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/30406
img Addthis img Ask img Blinklist img del.icio.us img Digg img Fark img Facebook img Google img Lycos img Ma.gnolia Add this page to Mister Wong Mr Wong img Netscape img Netvousz img Newsvine img Reddit img StumbleUpon img Slashdot img Tailrank img Technorati img Wink img Yahoo

Vote for Stronger Avian Flu Vaccine From GlaxoSmithKline:

  • Currently 6.00/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 6.00 out of 1 vote(s) cast.
Subscribe
Share It
Popular posts from our other blogs:
RSSrss
See all blog subscribe options
Google google
What is RSS?
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Newsletter

TwitterFollow us on Twitter!